Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy - The C-TRACT Trial

Status: Active_not_recruiting
Location: See all (29) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to determine if the use of image-guided, endovascular therapy (EVT) is an effective strategy with which to reduce Post Thrombotic Syndrome (PTS) disease severity and improve quality of life in patients with established disabling iliac-obstructive post thrombotic syndrome (DIO-PTS).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Disabling (moderate-to-severe) PTS, defined by a) presence of chronic venous disease \> or = 3 months duration in a leg with history of DVT, as determined by the site principal investigator or a physician co-investigator; and b) substantial limitation of daily activities or work capacity due to venous symptoms or an open venous ulcer, per the same investigator.

• Ipsilateral iliac vein obstruction documented within 12 months prior to consent by either:

‣ Occlusion or \>50% or = 50% stenosis of the iliac vein on venogram, CT venogram, MR venogram, or intravascular ultrasound (IVUS) or

⁃ Air plethysmography showing deep venous obstruction of the ipsilateral leg (reduced venous outflow fraction), and ultrasound showing echogenic material in the ipsilateral iliac vein and non-phasic continuous Doppler flow in the ipsilateral common femoral vein (CFV) in the presence of normal phasic Doppler flow in the contralateral CFV.

Locations
United States
California
St. Joseph's Vascular Institute
Orange
UCSF
San Francisco
Connecticut
Yale New Haven Hospital
New Haven
Delaware
Christiana Care Hospital
Newark
Iowa
University of Iowa
Iowa City
Illinois
Rush Medical Center
Chicago
University of Chicago
Chicago
NorthShore University Health System
Evanston
Northwestern University
Evanston
Indiana
Indiana University
Indianapolis
Maryland
University of Maryland
Baltimore
Missouri
Washington University School of Medicine
St Louis
Mississippi
University of Mississippi Medical Center
Jackson
North Carolina
University of North Carolina
Chapel Hill
Nebraska
St. Elizabeth's Hospital
Lincoln
New York
New York Presbyterian-Weill Cornell Medicine
New York
New York University Medical Center
New York
University of Vermont Health Network - CVPH
Plattsburgh
Staten Island Hospital
Staten Island
Ohio
University Hospitals Cleveland Medical Center
Cleveland
Jobst Vascular Institute
Toledo
Oklahoma
University of Oklahoma
Oklahoma City
Oregon
Oregon Health & Sciences University
Portland
Pennsylvania
Temple University
Philadelphia
Thomas Jefferson University Hospital
Philadelphia
University of Pittsburg
Pittsburgh
Virginia
University of Virginia
Charlottesville
Wisconsin
Gundersen Health System
La Crosse
Medical College of Wisconsin
Milwaukee
Time Frame
Start Date: 2018-07-02
Completion Date: 2026-04-27
Participants
Target number of participants: 225
Treatments
Experimental: Endovascular Therapy
Subjects randomized to EVT will receive the following:~1. imaging-guided iliac vein stent placement;~2. anticoagulant therapy for at least 6 months;~3. oral aspirin 81 mg for at least 6 months; and~4. optimal PTS therapy: medical, compression, lifestyle measures, and venous ulcer care
No_intervention: No-Endovascular Therapy - Control
Optimal PTS therapy: medical, compression, lifestyle measures, and venous ulcer care
Authors
Steven Smith, Anuj Malhotra, Benjamin Lind, Allen Chen, Saqib Zia, Gabor Matos, Sahira Kazanjian, Morey Blinder, Paul VanBemmelen, Jan Duus, Marc Passman, Akhilesh Sista, Neal Khurana, Robert Attaran, Minhajuddin Khaja, Pavan Kavali, Nicholas Sikalas, Irina Shakhnovich, Eric Hager, David Voigt, Rakesh Mehta, Drew Oostra, Ramona Gupta, John Kaufman, Ernest Chiu, Jun Xu, Colleen Moore, Steven Lentz, Mahmood Razavi, Rabih Chaer, Andrew Seiwert, Jonathan Lorenz, Amy Zhou, Yen Bui, Elaine Majerus, Jordan Tasse, Todd Kowalski, Rafael Cires-Drouet, Assaf Graif, Suresh Vedantham, Kenneth Cohen, Bedros Taslakian, Mazen Abu-Fadel, Jay Dalal, Luke Sewall, Bulent Arslan, Robert McLafferty, Naiem Nassiri, Zakaria Assi, Joonhyun Yoon, Daniel Sheeran, Babatunde Oriowo, James Cooper, Julio Lemos, Ann Zmuda, Kurt Ziegelbein, John Fish, Venu Vadlamudi, Alan Cohen, Osmanuddin Ahmed, Omar Tahir, Michael Sichlau, Christopher Grilli, Sabah Butty, Alfonso Tafur, Thomas DeLoughery, Antonios Gasparis, Laura Vick, Luis Eraso, Daniel Schmelka, Roy Smith, Kenneth Kolbeck, Kellie Brown, Demetrios Agriantonis, Robert Ford, Renee Jacobs, Sophia Afridi, Kristen Sanfilippo, Steven Sauk, Ezana Azene, Dimitrios Papadouris, Ryan Schenning, Teresa Carman, Karem Harth, George Behrens, Eric Hohenwalter, Francis Facchini, Michael Singh, Michael Verta, Michael Lankiewicz, Keith Sterling, Jihad Abbas, Brandon Key, Glenn Jacobowitz, Kush Desai, Shivi Jain, Julia Wilkinson, Nassir Rostambeigi, Andrew Leavitt, David Trost, Ronald Winokur, Daniel Leung, Thomas Maldonado, Rahat Noor, Pravin Patil, Carl Black, Vikram Rajpurohit, Raja Ramaswamy, Khanjan Nagarsheth, Henry Hsia, Gagan Kamal, Athanasios Vlahos, Rahul Razdan, Efthymios Avgerinos, Raj Kasthuri, Riyaz Bashir, Deepak Sudheendra, Stephen Kee, Michael Malinowski, Rachael Nicholson, Nilesh Goswami, Sabrina Islam, S. William Stavropoulos, Steven Deso, Stanley Kim, Clark Davis, Rakesh Navuluri, Kenneth Rholl, Resmi Charalel, Lowell Kabnick, Soo Rhee, Jonathan Schor, Mahalia Smith, Frank Ross, Matthew Scheidt, Alexander Ushinsky, Jeffrey Leef, Brady Stein, Kevin Schoepel, Richard Tapnio, Ajinkya Desai, George Kimbiris, Kurt Openshaw, Eric Yang, Gayle Gordillo, Joseph Schneider, Shang Loh, Mark Eskandari, Jason Crowner, Karlyn Martin, Sreekumar Madassery, Kanti Kolli, Bhavraj Khalsa, Alfred Lee, Hector Ferral, George Zlupko, Luke Wilkins, James Stone, Jonathan Deitch, William Marston, Angela Kokkosis, Natalie Weger, Thuong Van Ha, Gregory Kasper, Amish Patel, Alexa Levey, Akash Patel, Timothy Murphy
Sponsors
Leads: Washington University School of Medicine
Collaborators: Ontario Clinical Oncology Group (OCOG), Massachusetts General Hospital, Saint Luke's Mid America Heart Institute

This content was sourced from clinicaltrials.gov

Similar Clinical Trials